Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02018861 |
| Title | A Phase 1, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination With INCB039110 in Subjects With Previously Treated B-Cell Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Incyte Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama At Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35205 | United States | Details | |
| University of Michigan Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| Nyu Langone Laura and Isaac Perlmutter Cancer Center | New York | New York | 10016 | United States | Details | |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | United States | Details | |
| Greenville Health System Cancer Institute | Greenville | South Carolina | 29605 | United States | Details | |
| Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | United States | Details |